Pharmacokinetics of the estrogen receptor subtype-selective ligands, PPT and DPN: Quantification using UPLC-ES/MS/MS

Pyrazole Ligands:  Structure−Affinity/Activity Relationships and Estrogen Receptor-α-Selective Agonists

Shaun R. Stauffer, Christopher J. Coletta, Rosanna Tedesco et al. · Journal of Medicinal Chemistry · 2000 · 760 citations

Medicine, Endocrinology, Pharmacology +17

Estrogen Receptor-β Potency-Selective Ligands:  Structure−Activity Relationship Studies of Diarylpropionitriles and Their Acetylene and Polar Analogues

Marvin J. Meyers, Jun Sun, Kathryn E. Carlson et al. · Journal of Medicinal Chemistry · 2001 · 678 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Characterization of the Biological Roles of the Estrogen Receptors, ERα and ERβ, in Estrogen Target Tissues<i>in Vivo</i>through the Use of an ERα-Selective Ligand

Heather A. Harris, John A. Katzenellenbogen, Benita S. Katzenellenbogen · Endocrinology · 2002 · 369 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Response-Specific and Ligand Dose-Dependent Modulation of Estrogen Receptor (ER) α Activity by ERβ in the Uterus

Jonna Frasor, Daniel Barnett, Jeanne M. Danes et al. · Endocrinology · 2003 · 230 citations · Full text

Life Sciences, Endocrinology, Pharmacology +16

Exploration of Dimensions of Estrogen Potency

M. Jeyakumar, Kathryn E. Carlson, Jillian R. Gunther et al. · Journal of Biological Chemistry · 2011 · 95 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +17